Enovid was developed by Sanotize, a biotech company founded by Dr. Gilly Regev, who focuses on developing innovative treatments for various health conditions, particularly those caused by viral and bacterial infections. As an accomplished biochemist and entrepreneur, Dr. Regev has extensive experience researching the potential of nitric oxide.

Driven by her personal struggle with chronic sinusitis, Dr. Regev sought to explore the benefits of nitric oxide as a treatment for respiratory infections. In doing so, she uncovered its powerful antiviral properties and ability to inhibit virus replication. This breakthrough inspired her to create a product that could aid millions affected by respiratory illnesses, including COVID-19.